Unraveling the role of fibroblasts, FGF5 and FGFR2 in HER2-targeted therapies resistance and tumor progression

Oncotarget. 2020 Dec 8;11(49):4541-4543. doi: 10.18632/oncotarget.27829.
No abstract available

Keywords: FGF5; FGFR2; TAFs; breast cancer; trastuzumab.

Publication types

  • Editorial